$MDT (MEDTRONIC) — 8-K: MDT Q1 FY27 EPS $1.45 beats Street $1.39 by +4.5%; revenue +13.7% YoY

Medtronic printed adjusted EPS of $1.45, beating consensus of $1.39 by $0.06 (+4.5%). Q1 FY27 revenue was $9.756B, up 13.7% YoY. Management raised FY27 guidance to adjusted EPS of $5.94–$6.00 and organic sales growth of 7.25%–7.75%. Broad-based strength was led by Cardiovascular (+18.9% organic), with an extra fiscal week contributing approximately $570M to Q1 organic growth.

Medtronic printed adjusted EPS of $1.45, beating consensus of $1.39 by $0.06 (+4.5%). Q1 FY27 revenue was $9.756B, up 13.7% YoY. Management raised FY27 guidance to adjusted EPS of $5.94–$6.00 and organic sales growth of 7.25%–7.75%. Broad-based strength was led by Cardiovascular (+18.9% organic), with an extra fiscal week contributing approximately $570M to Q1 organic growth.